With the patent on Semaglutide expiring, Indian pharma companies including Dr Reddy’s, Natco, Sun Pharma, and Zydus are launching generic versions of Ozempic and similar drugs, expected to reduce monthly costs from Rs 10,000– Rs 12,000 to Rs 3,500–Rs 4,000.
